A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors

By Fury Matthew   Solit David   Su Yungpo   Rosen Neal   Sirotnak F.   Smith Robert   Azzoli Christopher   Gomez Jorge   Miller Vincent   Kris Mark   Pizzo Barbara   Henry Roxanne   Pfister David   Rizvi Naiyer  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 4, 2007-03 ,pp. : 467-475

Springer Publishing Company

Access to resources Recommend Favorite

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial

By Koukourakis M.I.   Kourousis C.   Kamilaki M.   Koukouraki S.   Giatromanolaki A.   Kakolyris S.   Kotsakis A.   Androulakis N.   Bahlitzanakis N.   Georgoulias V.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 838-844

Elsevier

Access to resources Recommend Favorite

Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors

By Masters Gregory   Brockstein Bruce   Mani Sridhar   Ratain Mark  

Medical Oncology, Vol. 20, Iss. 1, 2003-03 ,pp. : 7-12

Humana Press, Inc

Access to resources Recommend Favorite

A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma

By Chiorean E.   Dragovich Tomislav   Hamm John   Langmuir Virginia   Kroll Stewart   Jung Donald   Colowick Alan   Tidmarsh George   Loehrer Patrick  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 1019-1026

Springer Publishing Company

Access to resources Recommend Favorite

Phase I pharmacokinetic and sequence finding study of the combination of docetaxel and methotrexate in patients with solid tumours

By Louwerens M.   Smorenburg C.   Sparreboom A.   Loos W.J.   Verweij J.   de Wit R.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 497-504

Elsevier

Access to resources Recommend Favorite